UBS Raises Ferrari (RACE) Price Target to $563 Amid Strong Brand Leveraging
On November 28, 2025, UBS maintained its "Buy" rating for Ferrari (NYSE:RACE) and increased its price target to $563. This action follows the investment bank's view that Ferrari's previously outlined targets were conservative.
At the time of the announcement, Ferrari's stock was priced at $392.58. The luxury automaker's shares are currently trading at $391.96, marking an increase of 2.39% or $9.16. During the trading day, the stock fluctuated between a low of $384.18 and a high of $392.96. Over the past year, Ferrari (NYSE:RACE) has seen a high of $519.10 and a low of $372.31.
Ferrari N.V. continues to leverage its strong brand and high margins, emphasizing exclusivity and pricing power within the luxury car market. The company's order books are reportedly filled until 2027, a strategy that supports its margin durability and competitive advantage. Ferrari's market position is further strengthened by its focus on personalization and disciplined capacity management.
In contrast, competitor Porsche is navigating earnings challenges and business concentration risks. Despite offering diversification and dividend stability, Porsche faces pressure, underscoring Ferrari's strategic benefits in the performance-luxury sector.
- For historical information, visit: Ferrari History, Mission, and Ownership
- To understand the company's direction, visit: Ferrari Mission and Vision
- For details on financial performance, visit: Ferrari Financial Health
- For investor-specific insights, visit: Ferrari Investor Profile
Ferrari N.V. (RACE) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.